Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2012 NCI 5R01CA142838-03 Role of redox state in ovarian cancer response to cisplatin DANIEL, LARRY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $292,963
Ovarian Cancer 2012 NCI 5R01CA131407-05 Re-activating Memory T Cells in the Microenvironment of Human Tumors BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $335,374
Ovarian Cancer 2012 NCI 5R01CA077429-13 Basis for Lymphomagenesis in Akt2 Transgenic Mice TESTA, JOSEPH FOX CHASE CANCER CENTER PA $410,451
Ovarian Cancer 2012 NCI 5R01CA104996-08 Promoting Tumor Immunity by Cross-linking B7-DC PEASE, LARRY MAYO CLINIC MN $239,311
Ovarian Cancer 2012 NCI 5R01CA103937-08 Molecular Diagnostics for Malignant Effusion SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $328,003
Ovarian Cancer 2012 NCI 5R01CA144057-08 Evaluation of Vectors based on group B adenoviruses LIEBER, ANDRE UNIVERSITY OF WASHINGTON WA $313,989
Ovarian Cancer 2012 NCI 5R01CA129927-05 Discovery of Gene Expression Signatures in Cancer Stroma WEST, ROBERT STANFORD UNIVERSITY CA $378,263
Ovarian Cancer 2012 NCI 5R01CA124951-03 Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy FANG, BINGLIANG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $309,964
Ovarian Cancer 2012 NCI 1R41CA162648-01 Development of Novel Agents Targeting Genome Stability and Maintenance for Treati TURCHI, JOHN NERX BIOSCIENCES, INC. IN $229,680
Ovarian Cancer 2012 NCI 5R01CA079716-13 Ovarian Cancer: Epithelial Dedifferentiation XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $326,412
Ovarian Cancer 2012 NCI 5R01CA142776-03 The role of microRNA, mir-30d, in the initiation and progression of cancer ZHANG, LIN UNIVERSITY OF PENNSYLVANIA PA $322,040
Ovarian Cancer 2012 NCI 5R01CA138628-03 Role of the BMP SMADs in Oncogenesis PANGAS, STEPHANIE BAYLOR COLLEGE OF MEDICINE TX $354,370
Ovarian Cancer 2012 NCI 5R01CA133057-04 Prognostic markers for ovarian cancer MOK, SAMUEL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $309,964
Ovarian Cancer 2012 NCI 5F32CA144898-02 Role of Tumor Microenvironment in Ovarian Cancer Progression THOMPSON, MELISSA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $52,880
Ovarian Cancer 2012 NCI 5R01CA099985-06 Human Tregs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $216,969
Ovarian Cancer 2012 NCI 5R01CA132091-05 Targeted Nanoparticle DNA Therapy for Ovarian Cancer SAWICKI, JANET LANKENAU INSTITUTE FOR MEDICAL RESEARCH PA $266,946
Ovarian Cancer 2012 NCI 5R01CA148747-03 Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer CLIBY, WILLIAM MAYO CLINIC MN $317,411
Ovarian Cancer 2012 NCI 5R01CA101850-08 ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING BAE, YOU UNIVERSITY OF UTAH UT $263,045
Ovarian Cancer 2012 NCI 5R01CA129080-05 The Roles of HBXAP Gene in Ovarian Cancer SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $330,091
Ovarian Cancer 2012 NCI 5R01CA131200-04 Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases EBLEN, SCOTT MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $296,116
Ovarian Cancer 2012 NCI 5R01CA108970-08 CD4+ Memory T-Cells in Human Tumor Microenvironment BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $296,719
Ovarian Cancer 2012 NCI 5R01CA149429-03 The Mitochondrial Genome and Ovarian Cancer Risk PHELAN, CATHERINE H. LEE MOFFITT CANCER CTR & RES INST FL $604,624
Ovarian Cancer 2012 NICHD 5R01HD057110-05 Molecular Pathways Controlling Ovarian Gene Expression STOCCO, CARLOS UNIVERSITY OF ILLINOIS IL $288,726
Ovarian Cancer 2012 NCI 5R01CA123249-05 Regulation of Serine Protease HtrA1 and Chemoresponse SHRIDHAR, VIJI MAYO CLINIC MN $304,127
Ovarian Cancer 2012 NCI 5R01CA142832-03 Novel Biomarkers in Ovarian Cancer BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $347,562
Ovarian Cancer 2012 NCI 5R01CA109298-08 Ovarian Cancer: Mechanisms of Neuroendocrine Regulation SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $322,654
Ovarian Cancer 2012 NCI 5R01CA102707-08 Inhibition of Cytochrome c-induced Caspase Activation KORNBLUTH, SALLY DUKE UNIVERSITY NC $263,055
Ovarian Cancer 2012 NCI 5R01CA095175-09 Analysis of BRCA1 recombination functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $295,223
Ovarian Cancer 2012 NCI 5R01CA108990-08 Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer LOKSHIN, ANNA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $551,606
Ovarian Cancer 2012 NIEHS 5R01ES005775-20 Hypoxia, Genetic Instability and DNA Mismatch Repair GLAZER, PETER YALE UNIVERSITY CT $364,566
Ovarian Cancer 2012 NCI 1R01CA163345-01 Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics BUCKANOVICH, RONALD UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $313,450
Ovarian Cancer 2012 NCI 7R01CA086984-13 Regulation of Ovarian Carcinoma Proteinases STACK, MARY UNIVERSITY OF NOTRE DAME IN $295,464
Ovarian Cancer 2012 NCI 1R01CA163462-01 MUC1 Roles in ovarian cancer pathogenesis and immune therapy VLAD, ANDA MAGEE-WOMEN'S RES INST AND FOUNDATION PA $303,546
Ovarian Cancer 2012 NCI 1R21CA165916-01 Models for Consortium Level Analysis of GxE Interaction in Complex Disease IVERSEN, EDWIN DUKE UNIVERSITY NC $160,257
Ovarian Cancer 2012 NCI 5R01CA133117-04 Role of the Mullerian Tract in Ovarian Cancer Development DUBEAU, LOUIS UNIVERSITY OF SOUTHERN CALIFORNIA CA $326,066
Ovarian Cancer 2012 NCI 5R01CA157176-02 Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer BICKELL, NINA MOUNT SINAI SCHOOL OF MEDICINE NY $451,915
Ovarian Cancer 2012 NCI 5R21CA156944-02 Biophotonics Noninvasive Detection of Ovarian Cancer BACKMAN, VADIM NORTHWESTERN UNIVERSITY IL $316,438
Ovarian Cancer 2012 NCI 2P30CA006516-47 6051 Gynecologic Cancers BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $93,382
Ovarian Cancer 2012 NCI 5R03CA153815-02 The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy BOBER, SHARON DANA-FARBER CANCER INSTITUTE MA $87,500
Ovarian Cancer 2012 NCI 5R01CA123219-05 The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology MILLS, GORDON UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $307,535
Ovarian Cancer 2012 NCI 1R21CA164593-01 Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer ANDERSON, KAREN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $212,556
Ovarian Cancer 2012 NCI 5R01CA123233-05 Regulation of JNK-signaling molecules by the gep oncogenes DHANASEKARAN, DANNY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $241,288
Ovarian Cancer 2012 NCI 5R01CA136549-04 Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas LU, XIONGBIN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2012 NCI 1R15CA164622-01 Antiprogestin therapy for ovarian cancer TELLERIA, CARLOS UNIVERSITY OF SOUTH DAKOTA SD $425,596
Ovarian Cancer 2012 NCI 5R01CA155025-02 The role of a novel BRCA1 associated complex in DNA damage response and tumor sup WANG, BIN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2012 NCI 5R01CA138762-04 Splicing factors as therapeutic targets for the treatment of ovarian cancer BECK, WILLIAM UNIVERSITY OF ILLINOIS IL $307,810
Ovarian Cancer 2012 NCI 5R01CA148826-02 Characterizing Notch3 Signaling in Ovarian Cancer WANG, TIAN-LI JOHNS HOPKINS UNIVERSITY MD $340,300
Ovarian Cancer 2012 NCI 1R01CA157481-01A1 Bmi-1, a potential therapeutic target in ovarian cancer BHATTACHARYA, RESHAM MAYO CLINIC MN $344,461
Ovarian Cancer 2012 NIGMS 5SC1GM082340-03 The Fulvene Approach to the Syntheses of Antitumor Agents ERDEN, IHSAN SAN FRANCISCO STATE UNIVERSITY CA $265,939
Ovarian Cancer 2012 NCI 5R01CA099471-08 Gonadotropins & Cox-2 in Ovarian Cancer Prevention XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $375,915
Ovarian Cancer 2012 NCI 5R01CA131965-04 Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium SWISHER, ELIZABETH UNIVERSITY OF WASHINGTON WA $313,989
Ovarian Cancer 2012 NCI 5R21CA137681-03 A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers CHILES, THOMAS BOSTON COLLEGE MA $231,123
Ovarian Cancer 2012 NCI 5R01CA085289-09 DNA Methylation and Ovarian Cancer NEPHEW, KENNETH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $233,953
Ovarian Cancer 2012 NCI 5R03CA159080-02 Mammographic Breast Density and Ovarian Cancer WERNLI, KAREN GROUP HEALTH COOPERATIVE WA $80,000
Ovarian Cancer 2012 NCI 5R01CA136596-04 The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis CONNOLLY, DENISE FOX CHASE CANCER CENTER PA $323,047
Ovarian Cancer 2012 NCI 1R01CA158415-01A1 Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $390,388
Ovarian Cancer 2012 NIEHS 1R21ES020538-01A1 Novel triplex-engineered, BRCA1-mutated cell lines for research GLAZER, PETER YALE UNIVERSITY CT $207,136
Ovarian Cancer 2012 NCI 5R01CA141078-03 Multifunctional roles of homeobox gene DLX4 in ovarian cancer NAORA, HONAMI UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2012 NCI 1K23CA159391-01A1 Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus PEIKERT, TOBIAS MAYO CLINIC MN $164,160
Ovarian Cancer 2012 NCI 5R01CA131183-05 RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression LIU, JINSONG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $247,971
Ovarian Cancer 2012 NCI 1R03CA165082-01 Identification of regulatory cancer risk SNPs for chemoprevention discovery KLEIN, ROBERT SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $91,450
Ovarian Cancer 2012 NCI 1R21CA159002-01A1 Peptide-targeted alpha-particle emitting phage for ovarian cancer therapy. QUINN, THOMAS UNIVERSITY OF MISSOURI-COLUMBIA MO $203,732
Ovarian Cancer 2012 NCI 5R01CA140323-03 Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer GODWIN, ANDREW UNIVERSITY OF KANSAS MEDICAL CENTER KS $362,225
Ovarian Cancer 2012 NCI 5R01CA135006-04 Role of TbRIII in Regulating Motility and Invasion BLOBE, GERARD DUKE UNIVERSITY NC $423,323
Ovarian Cancer 2012 NCI 5R01CA158881-02 Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $540,181
Ovarian Cancer 2012 NCI 5R01CA136547-04 Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer PENG, KAH-WHYE MAYO CLINIC MN $507,051
Ovarian Cancer 2012 NCI 5R01CA134424-04 A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc KOSTUK, RAYMOND UNIVERSITY OF ARIZONA AZ $398,474
Ovarian Cancer 2012 NCI 5U10CA027469-32 Gynecologic Oncology Group DISAIA, PHILIP GYNECOLOGIC ONCOLOGY GROUP MD $10,681,725
Ovarian Cancer 2012 NCI 5R01CA115483-08 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA DAVIS CA $310,460
Ovarian Cancer 2012 NCI 5R01CA138556-04 Impact of exercise on ovarian cancer prognosis IRWIN, MELINDA YALE UNIVERSITY CT $606,353
Ovarian Cancer 2012 NCI 5R01CA136494-04 Molecular mechanism of antiangiogenic properties of gold nanoparticle MUKHERJEE, PRIYABRATA MAYO CLINIC MN $273,714
Ovarian Cancer 2012 NCI 5R01CA149260-03 Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy KUO, MACUS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,015
Ovarian Cancer 2012 NCI 1F31CA165844-01 Defining the role and regulation of the RhoGEF Ect2 in ovarian cancer cells HUFF, LAUREN UNIVERSITY OF N CAROLINA AT CHAPEL HILL NC $29,392
Ovarian Cancer 2012 NCI 5R01CA142783-03 Signaling in the ovarian cancer metastatic microenvironment SLACK-DAVIS, JILL UNIVERSITY OF VIRGINIA VA $309,964
Ovarian Cancer 2012 NCI 1R13CA165638-01 Ovarian Cancer: Prevention of the Disease and Its Recurrence EDWARDS, ROBERT MAGEE-WOMEN'S RES INST AND FOUNDATION PA $10,000
Ovarian Cancer 2012 NCI 5R01CA031841-32 Synthetic Studies on Tumor Promoters and Inhibitors WENDER, PAUL STANFORD UNIVERSITY CA $327,560
Ovarian Cancer 2012 NCI 5R01CA137041-04 MicroRNAs in Human Ovarian Cancer CHENG, JIN H. LEE MOFFITT CANCER CTR & RES INST FL $336,129
Ovarian Cancer 2012 NCI 5R01CA115780-07 Diagnosis of Ovarian Cancer by Confocal Microendoscopy GMITRO, ARTHUR UNIVERSITY OF ARIZONA AZ $276,708
Ovarian Cancer 2012 NCI 1R21CA165807-01 Tumor Suppressor Role of ARID1A SHIH, IE-MING JOHNS HOPKINS UNIVERSITY MD $176,175
Ovarian Cancer 2012 NCI 5R01CA136491-04 Development of an Assay for the Early Detection of Ovarian Cancer MOORE, RICHARD WOMEN AND INFANTS HOSPITAL-RHODE ISLAND RI $337,373
Ovarian Cancer 2012 NCI 5R01CA127913-05 MyD88-bearing tumors in immune-regulation and chemo-resistance MOR, GIL YALE UNIVERSITY CT $333,111
Ovarian Cancer 2012 NCI 5R44CA144586-03 IHC Test for BRCA1 Hereditary Ovarian Cancer HOLT, JEFFREY TISSUE GENETICS, INC. CO $399,246
Ovarian Cancer 2012 NCI 5R01CA157664-02 Initiation and evolution of the ovarian cancer microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $353,435
Ovarian Cancer 2012 NCI 5K07CA143047-03 Genetic Epidemiology of Ovarian and Prostate Cancer SIEH, WEIVA STANFORD UNIVERSITY CA $173,448
Ovarian Cancer 2012 NCI 5K08CA148887-03 Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer KHABELE, DINEO VANDERBILT UNIVERSITY MED CTR TN $159,084
Ovarian Cancer 2012 NCI 5R03CA143918-02 Characteristics of tubal ligation and risk of epithelial ovarian cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $96,177
Ovarian Cancer 2012 NCI 5R01CA120659-05 Role of a novel angiogenic factor, YKL-40, in breast cancer progression SHAO, RONG UNIVERSITY OF MASSACHUSETTS AMHERST MA $218,062
Ovarian Cancer 2012 NCI 5R01CA142081-03 Epidemiology of Ovarian Cancer in African-American Women SCHILDKRAUT, JOELLEN DUKE UNIVERSITY NC $2,226,299
Ovarian Cancer 2012 NCI 5R01CA039742-28 Epidemiology of Cancer in a Cohort of Older Women LAZOVICH, DEANN UNIVERSITY OF MINNESOTA TWIN CITIES MN $442,527
Ovarian Cancer 2012 NCI 5R01CA136512-04 BRCA1 Function in Post-Damage Nuclear Foci LIVINGSTON, DAVID DANA-FARBER CANCER INSTITUTE MA $511,599
Ovarian Cancer 2012 NCI 5R01CA135179-04 INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $421,283
Ovarian Cancer 2012 NCI 5R01CA138533-03 Multifunctional Nanotherapeutics for Cancer Treatment and Imaging MINKO, TAMARA RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $310,035
Ovarian Cancer 2012 NCI 5R01CA130911-05 Chimeric NKG2D receptors in ovarian cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $321,839
Ovarian Cancer 2012 NCI 5R01CA135312-05 Dendritic nanomedicine for cancer imaging and treatment TUNG, CHING-HSUAN METHODIST HOSPITAL RESEARCH INSTITUTE TX $301,913
Ovarian Cancer 2012 NCI 5R01CA149356-12 The Role of MicroRNAs in Tumor Progression PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $272,177
Ovarian Cancer 2012 NCI 5R01CA140933-04 Biobehavioral Influences and the Ovarian Tumor Microenvironment LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $524,647
Ovarian Cancer 2012 NCI 5R01CA126841-04 Regulatory T Cell Function in Ovarian Cancer MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $587,055
Ovarian Cancer 2012 NCI 5R01CA129142-04 Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women KINNEY, ANITA UNIVERSITY OF UTAH UT $550,522
Ovarian Cancer 2012 NIBIB 5R01EB011523-03 Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu CHOI, HAK SOO BETH ISRAEL DEACONESS MEDICAL CENTER MA $489,414
Ovarian Cancer 2012 NCI 5R01CA058598-14 Collaborative Genetic Study of Ovarian Cancer Risk GOODMAN, MARC UNIVERSITY OF HAWAII AT MANOA HI $471,383
Ovarian Cancer 2012 NCI 5R01CA131400-04 VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER SPRINGETT, GREGORY H. LEE MOFFITT CANCER CTR & RES INST FL $336,129
Ovarian Cancer 2012 NHLBI 1R21HL113439-01 Regulation of Macrophage Reverse Cholesterol Transport by BRCA1 SCHULMAN, IRA UNIVERSITY OF VIRGINIA VA $192,500
Ovarian Cancer 2012 NINR 5R01NR010735-05 Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed DONOVAN, HEIDI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $553,640
Ovarian Cancer 2012 NCI 5R37CA070867-15 Cancer Risk Reduction and Diet: A Cohort Study of Women ZHENG, WEI VANDERBILT UNIVERSITY MED CTR TN $948,106
Ovarian Cancer 2012 NCI 5R01CA135354-04 ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $306,953
Ovarian Cancer 2012 NCI 5R01CA132755-05 MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS YU, XIAOCHUN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $305,938
Ovarian Cancer 2012 NCI 5R01CA060731-18 AFAP-110 as a cSrc activator in breast cancer FLYNN, DANIEL COMMONWEALTH MEDICAL COLLEGE PA $227,829
Ovarian Cancer 2012 NIGMS 5R01GM032136-30 Molecular Recognition of Proteins and Ligand Design JORGENSEN, WILLIAM YALE UNIVERSITY CT $369,110
Ovarian Cancer 2012 NCI 5R01CA122443-06 Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology GOODE, ELLEN MAYO CLINIC MN $18,847
Ovarian Cancer 2012 NCI 5R01CA151570-02 Co-registered photoacoustic and ultrasound imaging for non-invasive ovarian can ZHU, QUING UNIVERSITY OF CONNECTICUT STORRS CT $323,537
Ovarian Cancer 2012 NCI 5R01CA154460-02 CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res SANTIN, ALESSANDRO YALE UNIVERSITY CT $344,277
Ovarian Cancer 2012 NCI 5K08CA151892-02 Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer SIMPKINS, FIONA UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $161,488
Ovarian Cancer 2012 NCI 5R21CA156224-02 Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $348,000
Ovarian Cancer 2012 NCI 1R01CA158119-01A1 Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $566,874
Ovarian Cancer 2012 NCI 5R01CA131582-04 Identification of ovarian cancer plasma biomarkers SPEICHER, DAVID WISTAR INSTITUTE PA $428,620
Ovarian Cancer 2012 NCI 1R01CA160669-01A1 Mitochondrial DNA and Ovarian Cancer Risk and Survival COOK, LINDA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $542,855
Ovarian Cancer 2012 NCI 5R03CA157212-02 Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers BUCHANAN, ADAM DUKE UNIVERSITY NC $84,884
Ovarian Cancer 2012 NCI 2R01CA111882-06 Regulation of Adhesion and Proteolysis in Ovarian Cancer LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $272,318
Ovarian Cancer 2012 NCI 5R01CA085566-08 Psychological Intervention for Ovarian Cancer Patients MANNE, SHARON UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $519,072
Ovarian Cancer 2012 NCI 5R01CA125231-06 A Multi-State Study of Cancer Treatment and Outcomes Among American Indians RAMSEY, SCOTT FRED HUTCHINSON CANCER RESEARCH CENTER WA $374,097
Ovarian Cancer 2012 NCI 5R00CA133190-05 Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer COWDEN DAHL, KAREN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $241,530
Ovarian Cancer 2012 NCI 2P30CA046592-24 6455 Cancer Genetics WICHA, MAX UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $301,699
Ovarian Cancer 2012 NCCAM 5R01AT005295-02 Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer HALES, DALE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $360,113
Ovarian Cancer 2012 NCI 5R21CA155479-02 Use of nanogels to target delivery of siRNA to cancer cells in mice MCDONALD, JOHN GEORGIA INSTITUTE OF TECHNOLOGY GA $247,687
Ovarian Cancer 2012 NIBIB 1R21EB014572-01A1 Intracellular delivery of proapoptotic peptide drugs for the treatment of cancer STAYTON, PATRICK UNIVERSITY OF WASHINGTON WA $256,194
Ovarian Cancer 2012 NCI 1R03CA162140-01A1 Parental age at birth and risk of adult-onset cancer in female offspring LU, YANI CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $84,000
Ovarian Cancer 2012 NCI 5R01CA141154-03 Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data PEARCE, CELESTE UNIVERSITY OF SOUTHERN CALIFORNIA CA $605,846
Ovarian Cancer 2012 NCI 5R01CA151374-03 Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients MARTIN, LAINIE FOX CHASE CANCER CENTER PA $426,421
Ovarian Cancer 2012 NIBIB 2R01EB007268-05 Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity YANG, JENNY GEORGIA STATE UNIVERSITY GA $446,352
Ovarian Cancer 2012 NCI 1R03CA167765-01 Effect of exercise on cortisol dysregulation in ovarian cancer survivors CARTMEL, BRENDA YALE UNIVERSITY CT $82,938
Ovarian Cancer 2012 NCI 5K05CA136967-04 Research and Mentoring on Energetic Factors and Cancer: Established Investigator BERNSTEIN, LESLIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $137,885
Ovarian Cancer 2012 NCI 5R01CA112240-07 The role of Fas as tumor promoter PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $294,148
Ovarian Cancer 2012 NCI 5R01CA160998-02 Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $399,919
Ovarian Cancer 2012 NCI 5R01CA127239-05 pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics NATARAJAN, AMARNATH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $270,598
Ovarian Cancer 2012 NCI 5U01CA152755-03 An integrated systems biology approach for ovarian cancer biomarker discovery DIAMANDIS, ELEFTHERIOS MT SINAI HOSP-SAMUEL LUNENFELD RES INST CANADA $190,288
Ovarian Cancer 2012 NCI 5U01CA152990-03 Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery SKATES, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $701,365
Ovarian Cancer 2012 NCI 5R21CA160917-02 Role of the Fractalkine Signaling in EOC BARBOLINA, MARIA UNIVERSITY OF ILLINOIS IL $168,249
Ovarian Cancer 2012 NCI 5K07CA131094-05 Epigentics and Female Reproductive Cancers PERRIN, MARY NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $139,320
Ovarian Cancer 2012 NCI 5U01CA084955-13 Atlantic Breast and Gynecologic Clinical Validation Center MARKS, JEFFREY DUKE UNIVERSITY NC $479,070
Ovarian Cancer 2012 NIDCR 5R03DE021438-02 Genetic Markers Associated with Epithelial Ovarian Cancer and Hypodontia MORFORD, LORRI UNIVERSITY OF KENTUCKY KY $111,375
Ovarian Cancer 2012 NIAID 5SC1AI089073-04 Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer SON, DEOK-SOO MEHARRY MEDICAL COLLEGE TN $358,962
Ovarian Cancer 2012 NCI 5R21CA155424-02 Enzyme-delivery scaffold technology for targeted cancer killing. LAVIE, ARNON UNIVERSITY OF ILLINOIS IL $231,674
Ovarian Cancer 2012 NCI 5K22CA138563-03 Obesity in ovarian cancer prognosis BANDERA, ELISA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $201,381
Ovarian Cancer 2012 NCI 1F30CA167895-01 Molecular analysis of the function of BRCA1-TONSL complexes HILL, SARAH HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $44,874
Ovarian Cancer 2012 NCI 5R44CA140047-04 Cancer Progeniyor Cell Markers CHEN, WEN-TIEN VITATEX, INC. NY $703,024
Ovarian Cancer 2012 NCI 1F31CA168180-01 A novel model system for risk assessment of BRCA carriers COCHRAN, RORY JOHNS HOPKINS UNIVERSITY MD $42,232
Ovarian Cancer 2012 NCI 1F32CA168309-01 A Role for Fatty Acid Binding Protein 4 in Ovarian Cancer Metastasis NIEMAN, KRISTIN UNIVERSITY OF CHICAGO IL $53,942
Ovarian Cancer 2012 NCI 5R03CA162511-02 Fish oil for the prevention and treatment of ovarian cancer HALES, DALE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $72,750
Ovarian Cancer 2012 NCI 5R01CA075334-15 MRI studies of angiogenesis in ovarian cancer NEEMAN, MICHAL WEIZMANN INSTITUTE OF SCIENCE ISRAEL $102,771
Ovarian Cancer 2012 NCI 5R01CA160541-02 Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer TAINSKY, MICHAEL WAYNE STATE UNIVERSITY MI $315,400
Ovarian Cancer 2012 NIGMS 8R21GM103536-02 Development of Nanoproteomic Technologies LEE, CHENG UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS MD $187,500
Ovarian Cancer 2012 NIGMS 5R01GM097495-02 Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration HOWE, ALAN UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $332,114
Ovarian Cancer 2012 NCI 1U01CA168409-01 COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS POWERS, SCOTT COLD SPRING HARBOR LABORATORY NY $1,405,573
Ovarian Cancer 2012 NCI 5U24CA160036-02 Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers CHAN, DANIEL JOHNS HOPKINS UNIVERSITY MD $1,875,068
Ovarian Cancer 2012 NCI 5R01CA158318-02 mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $334,591
Ovarian Cancer 2012 NCI 5R33CA147988-02 Development and Application of Novel Glycan-Specific Reagents to Facilitate Early MUDDIMAN, DAVID NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $353,783
Ovarian Cancer 2012 NCI 5U01CA152637-03 Breast and Ovary Cancer Clinical Validation Center LI, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $973,064
Ovarian Cancer 2012 NCI 5R43CA159478-02 Utrasensitive bioassays using palladium catalyzed chemical amplification LELENTAL, MARK BIOFORMATIX, INC. CA $100,578
Ovarian Cancer 2012 NCI 5U01CA151648-04 RNA Nanotechnology in Cancer Therapy GUO, PEIXUAN UNIVERSITY OF KENTUCKY KY $408,591
Ovarian Cancer 2012 NHGRI 5R21HG006415-02 Genetic Education to Promote Counseling Attendance after Surgical Treatment (GET VADAPARAMPIL, SUSAN H. LEE MOFFITT CANCER CTR & RES INST FL $208,750
Ovarian Cancer 2012 NCI 5U01CA151461-03 Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer O'HALLORAN, THOMAS NORTHWESTERN UNIVERSITY AT CHICAGO IL $396,261
Ovarian Cancer 2012 NCI 5R03CA162103-02 Bilateral oophorectomy and cancer risk and mortality in African American women BOGGS, DEBORAH BOSTON UNIVERSITY MEDICAL CAMPUS MA $61,751
Ovarian Cancer 2012 NCI 5R33CA155618-02 Array Microscope Assay for Cancer Cell Mechanics SUPERFINE, RICHARD UNIVERSITY OF N CAROLINA AT CHAPEL HILL NC $309,109
Ovarian Cancer 2012 NCI 5R21CA161478-02 Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer FANG, XIANJUN VIRGINIA COMMONWEALTH UNIVERSITY VA $195,098
Ovarian Cancer 2012 NCI 1U01CA168870-01 Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer ABBOTT, KAREN UNIVERSITY OF GEORGIA (UGA) GA $355,985
Ovarian Cancer 2012 NCI 1K99CA168987-01 Discovering genomic rearrangements under selection in serious ovarian cancer SALZMAN, JULIA STANFORD UNIVERSITY CA $110,132
Ovarian Cancer 2012 NCI 1R01CA163377-01A1 Role of EZH2 in Epithelial Ovarian Cancer ZHANG, RUGANG WISTAR INSTITUTE PA $316,168
Ovarian Cancer 2012 NCI 1R01CA163451-01A1 Psychological stress, associate biologic mediators, and ovarian cancer risk TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $469,872
Ovarian Cancer 2012 NCI 1R01CA163018-01A1 Prospective Study of Serum MIS and Gynecologic Cancer Risk DORGAN, JOANNE INSTITUTE FOR CANCER RESEARCH PA $578,744
Ovarian Cancer 2012 NCI 1R01CA164729-01A1 Integrative Cancer Genomics: Drivers, Pathways and Drugs PE'ER, DANA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $399,632
Ovarian Cancer 2012 NCI 1R01CA164122-01A1 B7-H1 Signaling in Ovarian Cancer CURIEL, TYLER UNIV OF TX HSC, SA TX $310,040
Ovarian Cancer 2012 NCI 2R01CA068682-21A1 Biomedical Applications of Expanded Porphyrins SESSLER, JONATHAN UNIVERSITY OF TEXAS AUSTIN TX $319,550
Ovarian Cancer 2012 NCI 1K08CA163603-01A1 Antibody directed delivery of short interfering RNA for the treatment of ovarian PALANCA-WESSELS, MARIA FRED HUTCHINSON CANCER RESEARCH CENTER WA $170,631
Ovarian Cancer 2012 NCI 1R21CA170195-01 An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9) DUPUY, ADAM UNIVERSITY OF IOWA IA $164,213
Ovarian Cancer 2012 NCI 5P01CA070970-14 0006 Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma JONES, RICHARD JOHNS HOPKINS UNIVERSITY MD $312,066
Ovarian Cancer 2012 NCI 5P30CA077598-14 5757 Women's Cancer DOWNS, LEVI UNIVERSITY OF MINNESOTA TWIN CITIES MN $36,859
Ovarian Cancer 2012 NCI 5P01CA087969-13 7547 Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $166,923
Ovarian Cancer 2012 NCI 5P01CA087969-13 7548 Statistical Methods ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $114,846
Ovarian Cancer 2012 NCI 5P01CA087969-13 7551 Biologic Specimen Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $473,805
Ovarian Cancer 2012 NCI 5U19CA148112-03 8865 Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $235,559
Ovarian Cancer 2012 NCI 5U19CA148112-03 8866 Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1) SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $704,637
Ovarian Cancer 2012 NCI 5U19CA148112-03 8867 Functional assessment of genes and common genetic risk variants in ovarian cancer SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $767,203
Ovarian Cancer 2012 NCI 5U19CA148112-03 8868 Genetic and environmental interaction analyses and risk prediction modeling SELLERS, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $707,617
Ovarian Cancer 2012 NCI 5P30CA118100-08 6320 Womens Cancers Research Program PROSSNITZ, ERIC UNIVERSITY OF NEW MEXICO NM $40,968
Ovarian Cancer 2012 NCI 5U54CA151459-03 8855 Next Generation Smart Nanoparticles ALIVISATOS, PAUL UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $981,050
Ovarian Cancer 2012 NCI 5U54CA151459-03 8856 Magneto-Nano Diagnostic and Analytical Devices for Cancer WANG, SHAN STANFORD UNIVERSITY CA $262,335
Ovarian Cancer 2012 NCI 5U54CA151459-03 8858 Integration of Nano-Molecular Imaging and Nanosensors GAMBHIR, SANJIV STANFORD UNIVERSITY CA $177,117
Ovarian Cancer 2012 NCI 5U54CA151459-03 8865 Pilot Projects GAMBHIR, SANJIV STANFORD UNIVERSITY CA $58,394
Ovarian Cancer 2012 NCI 5U54CA151662-03 8769 Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer GERNGROSS, TILLMAN DARTMOUTH COLLEGE NH $295,924
Ovarian Cancer 2012 NCI 5U54CA151662-03 8772 Magnetic nanoparticle Immunotherapy against Ovarian Cancer CONEJO-GARCIA, JOSE DARTMOUTH COLLEGE NH $318,011
Ovarian Cancer 2012 NCI 5U54CA151662-03 8775 Toxicology, Pathology and Biodistribution Core (TPB Core) LEWIS, LIONEL DARTMOUTH COLLEGE NH $174,166
Ovarian Cancer 2012 NCI 5P30CA014236-38 6412 Breast and Ovarian Oncology BERCHUCK, ANDREW DUKE UNIVERSITY NC $26,728
Ovarian Cancer 2012 NCI 5P30CA006927-49 8440 Histopathology SEIDEN, MICHAEL FOX CHASE CANCER CENTER PA $57,099
Ovarian Cancer 2012 NCI 5P50CA083636-14 7964 Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $147,388
Ovarian Cancer 2012 NCI 5P50CA083636-14 7965 Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $272,565
Ovarian Cancer 2012 NCI 5P50CA083636-14 7966 MicroRNA Signature of Poorly Resectable Ovarian Cancer TEWARI, MUNEESH FRED HUTCHINSON CANCER RESEARCH CENTER WA $210,642
Ovarian Cancer 2012 NCI 5P50CA083636-14 7967 Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient TANIGUCHI, TOSHIYASU FRED HUTCHINSON CANCER RESEARCH CENTER WA $280,192
Ovarian Cancer 2012 NCI 5P50CA083636-14 7968 Vaccinating against IGFBP-2 to prevent ovarian cancer relapse DISIS, MARY UNIVERSITY OF WASHINGTON WA $346,643
Ovarian Cancer 2012 NCI 5P50CA083636-14 7969 Leadership and Administration Core URBAN, NICOLE FRED HUTCHINSON CANCER RESEARCH CENTER WA $164,031
Ovarian Cancer 2012 NCI 5P50CA083636-14 7970 Clinical Specimen Management and Characterization Core KNUDSEN, BEATRICE FRED HUTCHINSON CANCER RESEARCH CENTER WA $308,270
Ovarian Cancer 2012 NCI 5P50CA083636-14 7971 Participant Recruitment, Enrollment and Characterization Core DRESCHER, CHARLES FRED HUTCHINSON CANCER RESEARCH CENTER WA $247,763
Ovarian Cancer 2012 NCI 5P50CA083636-14 7972 Biostatistics and Informatics Core MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $185,706
Ovarian Cancer 2012 NCI 5P50CA083636-14 7973 Developmental Research Program MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $66,479
Ovarian Cancer 2012 NCI 5P50CA083636-14 7974 Career and Mentoring Development Program COLLINS, STEVEN FRED HUTCHINSON CANCER RESEARCH CENTER WA $66,479
Ovarian Cancer 2012 NCI 5P50CA083639-13 7762 P1 - Early Detection of Epithelial Ovarian Cancer BAST, ROBERT UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $864,877
Ovarian Cancer 2012 NCI 5P50CA083639-13 7764 P2 - Targeting DII4-Notch Signaling in Ovarian Cancer SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $207,175
Ovarian Cancer 2012 NCI 5P50CA083639-13 7767 P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $208,290
Ovarian Cancer 2012 NCI 5P50CA083639-13 7768 P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne MILLS, GORDON UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $184,534
Ovarian Cancer 2012 NCI 5P50CA083639-13 7770 P5 - Gene-modified MSCs for Controlling Ovarian Cancer MARINI, FRANK UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $186,856
Ovarian Cancer 2012 NCI 5P50CA083639-13 7771 Administrative Core GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $26,159
Ovarian Cancer 2012 NCI 5P50CA083639-13 7772 Biostatistics, Bioinformatics and Systems Biology (BBSB) Core ATKINSON, E UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $287,346
Ovarian Cancer 2012 NCI 5P50CA083639-13 7773 Pathology Core BROADDUS, RUSSELL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $121,897
Ovarian Cancer 2012 NCI 5P50CA083639-13 7774 Developmental Research Program GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $84,085
Ovarian Cancer 2012 NCI 5P50CA083639-13 7775 Career Developmental Program GERSHENSON, DAVID UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $56,057
Ovarian Cancer 2012 NCI 5P50CA136393-04 7923 Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC MN $350,594
Ovarian Cancer 2012 NCI 5P50CA136393-04 7924 Mechanisms of Immune Suppression in Ovarian Cancer KNUTSON, KEITH MAYO CLINIC MN $327,530
Ovarian Cancer 2012 NCI 5P50CA136393-04 7925 Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer GALANIS, EVANTHIA MAYO CLINIC MN $372,958
Ovarian Cancer 2012 NCI 5P50CA136393-04 7926 Flavopiridol Reverses Platinum Resistance in Ovarian Cancer BIBLE, KEITH MAYO CLINIC MN $238,831
Ovarian Cancer 2012 NCI 5P50CA136393-04 7927 Administration Core HARTMANN, LYNN MAYO CLINIC MN $234,806
Ovarian Cancer 2012 NCI 5P50CA136393-04 7928 Biospecimens/Patient Registry Core BELL, DEBRA MAYO CLINIC MN $197,531
Ovarian Cancer 2012 NCI 5P50CA136393-04 7929 Biostatistics Core OBERG, ANN MAYO CLINIC MN $204,874
Ovarian Cancer 2012 NCI 5P50CA136393-04 7930 Animal Models KNUTSON, KEITH MAYO CLINIC MN $171,472
Ovarian Cancer 2012 NCI 5P50CA136393-04 7931 Developmental Research Program KAUFMANN, SCOTT MAYO CLINIC MN $134,270
Ovarian Cancer 2012 NCI 5P50CA136393-04 7932 Career Development Program COUCH, FERGUS MAYO CLINIC MN $67,134
Ovarian Cancer 2012 NCI 5U54CA151819-03 8878 Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an HOOD, LEROY INSTITUTE FOR SYSTEMS BIOLOGY WA $703,861
Ovarian Cancer 2012 NCI 5U54CA151819-03 8879 Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy RADU, CAIUS UNIVERSITY OF CALIFORNIA LOS ANGELES CA $367,673
Ovarian Cancer 2012 NCI 5U54CA151819-03 8883 Administrative Core HEATH, JAMES CALIFORNIA INSTITUTE OF TECHNOLOGY CA $111,996
Ovarian Cancer 2012 NCI 5P50CA083638-14 7949 Gene Methylation Signatures for Predictive Classification of Response to Therapy CAIRNS, PAUL FOX CHASE CANCER CENTER PA $785,372
Ovarian Cancer 2012 NCI 5P50CA083638-14 7950 Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C DALY, MARY FOX CHASE CANCER CENTER PA $343,633
Ovarian Cancer 2012 NCI 5P50CA083638-14 7951 Therapeutic Micro RNA Strategies for Ovarian Cancer HAMILTON, THOMAS FOX CHASE CANCER CENTER PA $426,838
Ovarian Cancer 2012 NCI 5P50CA083638-14 7952 Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O GODWIN, ANDREW FOX CHASE CANCER CENTER PA $242,445
Ovarian Cancer 2012 NCI 5P50CA083638-14 7955 Advancing T cell Therapy for Ovarian Cancer COUKOS, GEORGE UNIVERSITY OF PENNSYLVANIA PA $450,053
Ovarian Cancer 2012 NCI 5P50CA083638-14 7956 Administrative Core SEIDEN, MICHAEL FOX CHASE CANCER CENTER PA $51,659
Ovarian Cancer 2012 NCI 5U54CA151881-03 5122 Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA TORCHILIN, VLADIMIR NORTHEASTERN UNIVERSITY MA $754,495
Ovarian Cancer 2012 NCI 5U54CA151881-03 5124 Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance MINKO, TAMARA RUTGERS THE STATE UNIVERSITY OF NJ NJ $266,219
Ovarian Cancer 2012 NCI 5U54CA151668-03 8844 Multistage Vectors (MSV) for Ovarian Cancer Therapeutics LOPEZ-BERESTEIN, GABRIEL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $394,913
Ovarian Cancer 2012 NCI 5U54CA151668-03 8845 Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature SOOD, ANIL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $366,609
Ovarian Cancer 2012 NCI 5U54CA151668-03 8847 Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $318,072
Ovarian Cancer 2012 NCI 5U54CA151884-03 5023 Nanoformulations for siRNA Delivery to Ovarian Cancer SHARP, PHILLIP MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $255,250
Ovarian Cancer 2012 NCI 5F31CA145736-02 Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer WILLIAMS, EVA CHRISTABEL UNIVERSITY OF SOUTH FLORIDA FL $32,609
Ovarian Cancer 2012 NCI 1R21CA164839-01A1 Linking tumor chemoresistance to TLR variants that mediate damage chain reaction SCHOLLER, NATHALIE UNIVERSITY OF PENNSYLVANIA PA $208,800
Ovarian Cancer 2012 NCI 7R01CA109545-06 Receptor Cross-Talk in Early Metastatic Dissemination STACK, MARY UNIVERSITY OF NOTRE DAME IN $298,049
Ovarian Cancer 2012 NHLBI 2R44HL099217-02A1 ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial FANGER, MICHAEL CELDARA MEDICAL, LLC NH $1,399,888
Ovarian Cancer 2012 NCI 2R44CA139841-02A1 A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC PRABHAKARPANDIAN, BALABHASKAR CFD RESEARCH CORPORATION AL $633,309
Ovarian Cancer 2012 NCI 1R41CA168228-01A1 Integrin Targeted Therapy for the Treatment of Ovarian Cancer MARKLAND, FRANCIS APPLIED INTEGRIN SCIENCES, INC. CA $299,849
Ovarian Cancer 2012 NCI 3R01CA133117-04S1 Role of the Mullerian Tract in Ovarian Cancer Development DUBEAU, LOUIS UNIVERSITY OF SOUTHERN CALIFORNIA CA $58,236
Ovarian Cancer 2012 NCI 1F31CA165528-01A1 The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2 PRICE, MELISSA H. LEE MOFFITT CANCER CTR & RES INST FL $42,232
Ovarian Cancer 2012 NCI 1F30CA171715-01 Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer LOU, DIANNE UNIVERSITY OF TEXAS AUSTIN TX $32,232
Ovarian Cancer 2012 NCI 3U10CA027469-31S2 Gynecologic Oncology Group DISAIA, PHILIP GYNECOLOGIC ONCOLOGY GROUP MD $109,000
Ovarian Cancer 2012 NCI 1R03CA171617-01 Ovarian Cancer Initiating Cells: Metabolic Characterization MURPHY, SUSAN DUKE UNIVERSITY NC $78,500
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer